Mania with psychotic feature induced by the use of pramipexole in Parkinson's disease: A case report

dc.contributor.authorMeriç, Ceren
dc.contributor.authorPirdogan, Efruz
dc.contributor.authorGünday Toker, Ömür
dc.contributor.authorTekin, Atilla
dc.contributor.authorBakim, Bahadir
dc.contributor.authorÇelik, Selime
dc.date.accessioned2025-01-27T19:04:02Z
dc.date.available2025-01-27T19:04:02Z
dc.date.issued2014
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractParkinson's disease (PD), which is frequently accompanied by psychiatric symptoms, is a neurodegenerative disease characterized by movement disorders. Psychiatric symptoms may be the direct result of PD, comorbid pathologies, or its pharmacotherapy. Pramipexole, as other dopamine agonists used in the treatment of PD, has a tendency to induce psychotic and manic symptoms due to central dopaminergic stimulation. Herein we present a PD patient that had mania with psychotic feature due to dopamine agonist treatment, which is not commonly reported.
dc.identifier.issn1300-2163
dc.identifier.issue3
dc.identifier.pmid25219695
dc.identifier.scopus2-s2.0-84907584406
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://hdl.handle.net/20.500.12428/13763
dc.identifier.volume25
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Association of Nervous and Mental Health
dc.relation.ispartofTurk Psikiyatri Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250125
dc.subjectMania; Parkinson's disease; Pramipexole; Psychosis
dc.titleMania with psychotic feature induced by the use of pramipexole in Parkinson's disease: A case report
dc.typeArticle

Dosyalar